Syndopa 275 mg is a combination medication used to treat Parkinson’s disease and related motor symptoms. It contains Levodopa (250 mg) and Carbidopa (25 mg). Levodopa acts as a precursor to dopamine, a neurotransmitter that is deficient in the brains of people with Parkinson’s disease. Carbidopa helps prevent the premature conversion of Levodopa into dopamine outside the brain, allowing more Levodopa to reach the brain and enhancing its effectiveness. This combination helps reduce symptoms such as tremors, stiffness, slowness of movement, and muscle rigidity, thereby improving mobility and daily functioning.